866807-27-4 Usage
General Description
3-Amino-6-chloropyridine-2-carboxylic acid is an organic compound with the molecular formula C6H5ClN2O2. It is a derivative of pyridine and contains both amino and carboxylic acid functional groups. 3-Amino-6-chloropyridine-2-carboxylic acid is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has been studied for its potential biological activities, including as an inhibitor of certain enzymes and as an anti-inflammatory agent. Additionally, 3-Amino-6-chloropyridine-2-carboxylic acid has been investigated for its potential role in the treatment of various diseases and disorders, making it a valuable compound for research and development in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 866807-27-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,8,0 and 7 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 866807-27:
(8*8)+(7*6)+(6*6)+(5*8)+(4*0)+(3*7)+(2*2)+(1*7)=214
214 % 10 = 4
So 866807-27-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H5ClN2O2/c7-4-2-1-3(8)5(9-4)6(10)11/h1-2H,8H2,(H,10,11)
866807-27-4Relevant articles and documents
SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2)
-
, (2021/01/29)
The present invention relates to compounds of formula (I). The compounds may be used to modulate the acetyl coenzyme A synthetase short chain 2 (ACSS2) protein and may thereby treat, ameliorate or prevent a disease selected from cancer, bacterial infection, viral infection, parasitic infection, fungal infection, neurodegenerative disease, neurological disorder, cerebrovascular disease, cardiovascular disease, non- alcoholic fatty liver disease and obesity. Alternatively, or additionally, the compounds maybe used to promote healthy ageing.
NEW CHEMICAL COMPOUNDS
-
Page/Page column 118, (2010/04/03)
The present invention encompasses compounds of general formula (1) wherein the units W, A, L, Q1 and QH are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.
